Cerevel Therapeutics Hldng I shares owned by Vanguard Group
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $293M | 7.2M | 40.89 |
| 2024-03-31 | $316M | 7.5M | 42.27 |
| 2023-12-31 | $313M | 7.4M | 42.40 |
| 2023-09-30 | $139M | 6.4M | 21.83 |
| 2023-06-30 | $180M | 5.7M | 31.79 |
| 2023-03-31 | $149M | 6.1M | 24.39 |
| 2022-12-31 | $191M | 6.0M | 31.54 |
| 2022-06-30 | $133M | 5.0M | 26.44 |
| 2022-03-31 | $168M | 4.8M | 35.01 |
| 2021-09-30 | $138M | 4.7M | 29.50 |
| 2021-06-30 | $90M | 3.5M | 25.62 |
| 2021-03-31 | $44M | 3.2M | 13.75 |
| 2020-12-31 | $52M | 3.1M | 16.66 |